UCB’s bimekizumab issued NICE recommendation for severe plaque psoriasis

2nd August 2021 Uncategorised 0

Bimekizumab is the first to follow NICE’s new expedited appraisal process

More: UCB’s bimekizumab issued NICE recommendation for severe plaque psoriasis
Source: News